No 03 2022

On May 12, US President Trump signed an Executive Order to bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations.

The Anglonordic Life Science Conference concluded its 21st edition at London’s historic County Hall on April 3rd, 2025. With over 350 registered delegates, the event celebrated over two decades of driving innovation and deepening collaboration across the UK, Nordic region, and Europe. More than ever before, this year showcased the power of cross-border partnerships and set the tone for an even more impactful future in the life sciences.

This collaboration represents a powerful alignment of capabilities designed to address the growing complexity of global regulatory requirements, the companies state.

The financing was supported by existing investors; the European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), and Stephen Industries Inc Oy.

The US Food and Drug Administration (FDA) has approved Aqilion's IND (investigational new drug) application for the drug candidate AQ280.

The policy prevents the NSF from awarding new research grants and from supplying allotted funds for existing grants, such as those that receive yearly increments of money.

The company has announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved commercial-scale manufacturing process.